Showing results (151-160 of 272) with videos related to

Sort By:
Pageof 28
Pharmaceutics|December 28, 2021
A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in MiceNouran R R Zaid, Peter Kletting, Gordon Winter, et al.
World Journal of Gastroenterology|December 10, 2009
Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumorDaniel Kaemmerer, Vikas Prasad, Wolfgang Daffner, et al.
BMJ Case Reports|November 29, 2024
Remission of longstanding metastatic paraganglioma in a patient after use of zoledronic acidJustin Schutte, Mahta Mardani, Katherine Weilbaecher, et al.
Frontiers in Oncology|December 3, 2025
The implication of aberrant NRF2 activation in management of female cancersMankgopo Kgatle, Saidon Mbambara, Olalekan Fadebi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized TreatmentLuis David Jiménez-Franco, Gerhard Glatting, Vikas Prasad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2025
Organ and tumour dosimetry of 177Lu-rhPSMA-10.1, a novel PSMA-targeted therapy: results from a Phase I trialJames Nagarajah, Hyun Kim, Luke Nordquist, et al.
Seminars in Nuclear Medicine|March 7, 2025
Theranostics in Lung Neuroendocrine TumorsIndraja D Dev, Ameya D Puranik, Nikolaos A Trikalinos, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 13, 2019
68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancerJonathan Damjanovic, Jan-Carlo Janssen, Vikas Prasad, et al.
Pageof 28